ThermoDox In Combination With Radio Frequency Ablation Liver Phase I Results Presented At WCIO 2008 & Best Of ASCO
June 30th, 2008
Celsion Corporation (NASDAQ: CLN) announced today that the interim results from its second Phase I liver cancer confirmation study of ThermoDox in combination with Radio Frequency Ablation (RFA) treating patients with primary and metastatic liver cancer were presented at both Oral and Poster presentation at the WCIO 2008 and Best of ASCO® conference.
Posted in Uncategorized | No Comments »
Patients with metastatic renal cell carcinoma (RCC) are often treated with cytokine therapy, although the effect is modest and second-line therapy is often warranted. Relatively little is known regarding the impact on health-related quality of life (HRQOL) in cytokine-refractory patients. This study examined the HRQOL of patients with metastatic RCC treated with axitinib, a new targeted therapy that affects the vessels supplying blood to the tumor.
Systematic transrectal ultrasound-guided biopsy (TRUSBx) is the gold standard for detecting prostate cancer. This systematic approach is characterized by low sensitivity (39-52%) and high specificity (81-82%). Magnetic resonance (MR)-guided biopsy techniques are becoming more and more available, but there is no current consensus on the optimal technique.
Pregnancy seems to confer some protection against bladder cancer in mice, scientists have found. Female mice that had never become pregnant had approximately 15 times as much cancer in their bladders as their counterparts that had become pregnant, according to new findings by investigators at the University of Rochester Medical Center.
Scientists at Dana-Farber Cancer Institute report they have blocked the development of prostate tumors in cancer-prone mice by knocking out a molecular unit they describe as a “powerhouse” that drives runaway cell growth.
According to the American Academy of Dermatology (AAD), there will be approximately one million new cases of skin cancer diagnosed in the United States in 2008. The AAD says that about one in every five Americans will develop skin cancer some time during his/her lifetime.
Scientists at Wake Forest University Baptist Medical Center are about to embark on a human trial to test whether a new cancer treatment will be as effective at eradicating cancer in humans as it has proven to be in mice.
New data show that use of CAPHOSOL® (http://www.caphosol.com/), an advanced oral electrolyte solution, resulted in both favorable impact on rates and severity of oral mucositis (OM) in cancer patients undergoing chemotherapy and radiation therapy.
ORLANDO, FL (UroToday.com) - Dr. Abraham Morgentaler and colleagues examined the relationship between testosterone (T) levels and PSA in hypogonadal men.184 patients with symptomatic hypogonadism (T <300 ng/dL) and PSA of ≤4.0 ng/mL were included in the study. All patients underwent a prostate biopsy prior to initiation of androgen supplementation therapy.
ORLANDO, FL (UroToday.com) - The authors explored patterns of recurrence, muscle invasion, and disease specific mortality in patients with bladder carcinoma in situ (CIS) who responded to an induction course with intravesical BCG immunotherapy.